Related terms
- Mild cognitive impairmentMCI
- A noticeable decline in memory or thinking that is more than normal aging but does not seriously interfere with daily life. Some people with it go on to develop dementia, and some do not.
- Dementia
- An umbrella term for a decline in memory and thinking severe enough to interfere with daily life. Alzheimer’s disease is the most common cause.
- Mental acuity
- An informal term for how sharp thinking feels: attention, memory, processing speed and clear reasoning. It is not a diagnosis. In studies it is measured with specific tests rather than the general term.
Research that mentions cognitive decline
9 studies in our archive have this term in the title. The newest are below.
Frequency-specific photobiomodulation at theta and gamma enhances cognitive networks and mitigates age-related decline
In aged rats, PBM reduced Iba-1 in prefrontal cortex and hippocampus, enhanced NeuN in prefrontal cortex, and decreased p38 and BCL-2 in the hippocampus.
Prediction of treatment responsiveness to home-based transcranial photobiomodulation (tPBM) intervention for cognitive decline using fNIRS concurrently recorded during tPBM
We explored the feasibility of applying graph-theoretical network analysis to fNIRS data for the early identification of non-responders to tPBM treatment before its completion.
Machine-Learning-Based Prediction of Photobiomodulation Effects on Older Adults With Cognitive Decline Using Functional Near-Infrared Spectroscopy
To the best of our knowledge, this is the first study to demonstrate the feasibility of predicting the tPBM efficacy. Our approach is expected to contribute to more efficient treatment planning by excluding ineffective treatment options.
Photobiomodulation regulates astrocyte activity and ameliorates scopolamine-induced cognitive behavioral decline
DISCUSSION: These findings indicate the possibility of behavioral and histological improvement due to PBM in scopolamine-induced CNS alteration, which mimics AD.
Photobiomodulation and visual stimulation against cognitive decline and Alzheimer's disease pathology: A systematic review
DISCUSSION: This review highlights PBM and VS as promising light-based therapeutic approaches against AD brain neuropathology and related cognitive decline, clarifying the most effective light parameters for further preclinical and clinical testing and use.
Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study
After five days of PBM therapy targeting the prefrontal cortex, sleep efficiency and N-back cognitive performance were improved on the fifth day.
Read this with care
- This entry is general information, not medical advice. See the disclaimer.
- Definitions are written for readers new to the field and may be simplified. Check the full paper when it matters.
- Found a mistake? Tell us.